Literature DB >> 7651818

A functional p53-responsive intronic promoter is contained within the human mdm2 gene.

A Zauberman1, D Flusberg, Y Haupt, Y Barak, M Oren.   

Abstract

The mdm2 gene is a target for transcriptional activation by the p53 tumor suppressor gene product. Previous work has revealed that the mouse mdm2 gene contains two promoters: one is located upstream to the gene and is active in the absence of p53, the other resides within the first intron and requires p53 for transcriptional activity. To determine whether this unique promoter activation pattern is biologically important, we investigated the structure and function of the corresponding region of the human mdm2 (hmdm2) gene. We report here that the hmdm2 gene also contains an intronic, p53-dependent promoter. The structural features of this promoter are highly conserved between mouse and man, as opposed to the lack of conservation of the first exon. This promoter is triggered in vivo in the presence of activated wild type p53, leading to the production of novel mRNA species. The intronic hmdm2 promoter contains two tandem p53 binding elements. Deletion analysis suggests that optimal promoter activity requires the simultaneous binding of p53 to both elements; this may serve to prevent premature triggering of the promoter by p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651818      PMCID: PMC307078          DOI: 10.1093/nar/23.14.2584

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

4.  Binding of a simian virus 40 T antigen-related protein to DNA.

Authors:  R D McKay
Journal:  J Mol Biol       Date:  1981-01-25       Impact factor: 5.469

5.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.

Authors:  J Chen; J Lin; A J Levine
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  MDM2 gene amplification in metastatic osteosarcoma.

Authors:  M Ladanyi; C Cha; R Lewis; S C Jhanwar; A G Huvos; J H Healey
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

9.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

Authors:  S S Fakharzadeh; S P Trusko; D L George
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.

Authors:  Y Barak; M Oren
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  99 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

Review 3.  Upstream open reading frames as regulators of mRNA translation.

Authors:  D R Morris; A P Geballe
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.

Authors:  R Ralhan; A Sandhya; M Meera; W Bohdan; S K Nootan
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

5.  Cotranscriptional exon skipping in the genotoxic stress response.

Authors:  Martin Dutertre; Gabriel Sanchez; Marie-Cécile De Cian; Jérôme Barbier; Etienne Dardenne; Lise Gratadou; Gwendal Dujardin; Catherine Le Jossic-Corcos; Laurent Corcos; Didier Auboeuf
Journal:  Nat Struct Mol Biol       Date:  2010-10-24       Impact factor: 15.369

6.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

7.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

Review 9.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

10.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.